Cadrenal Therapeutics (CVKD) Financials: Revenue & Earnings

CVKD price $0.92 -0.02 -2.13%

Ticker
CVKD
Price
$0.92
Change
-0.02 -2.13%
Market cap ?
$3.29M
P/E ?
-0.20
Forward P/E ?
0.11
Dividend yield ?
0.00%
Beta ?
1.95
Sector
Healthcare
Industry
Biotechnology

Financials

2022202320242025
0000

Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation…

Fair value

CVKD fair value $335.03. Price $0.92. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CVKD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.91——
2026-08-13-1.14-1.42——
2026-05-07-1.04-1.51——
2026-03-31-1.41-1.17——
2025-11-10-1.31-1.55——
2025-08-11-1.87-1.60——
2025-05-08-2.09-1.64——
2025-03-13-2.74-1.712.13K—
2024-11-07-2.18-1.83——
2024-08-07-2.25-19.04——
2024-05-09-1.50-1.05——
2024-03-11-0.75-1.20——
2023-11-09-1.05-1.05——
2023-08-10-1.35———
2023-05-10-0.41———
2023-03-30-6.46———
2022-09-30-0.09———
2022-06-30-0.04———
2022-03-31-0.02———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-09Pham Quang XBuy200.00K$0.91182.00K
2026-10-09Golden Lee ScottBuy75.00K$0.9168.25K
2026-10-09MURPHY JOHN RAYMONDBuy75.00K$0.9168.25K
2026-10-09Cole Jeffrey ScottBuy150.00K$0.91136.50K
2026-10-09WILSON GLYNNBuy75.00K$0.9168.25K
2026-06-29Pham Quang XSell7.40K$3.0322.42K
2026-06-26Pham Quang XSell9.03K$3.0527.54K
2026-06-25Pham Quang XSell2.13K$3.006.38K
2026-06-23Pham Quang XSell2.28K$3.207.29K
2026-06-22Pham Quang XSell9.17K$3.5532.54K
2026-06-17Pham Quang XSell513$3.161.62K
2026-06-16Pham Quang XSell3.61K$3.1811.49K
2026-06-15Pham Quang XSell3.67K$3.5813.12K
2026-06-12Pham Quang XSell13.00K$3.9451.20K
2026-06-11Pham Quang XSell1.46K$4.126.02K
2026-06-10Pham Quang XSell3.50K$4.2114.73K
2026-06-09Pham Quang XSell12.99K$4.0652.75K
2026-06-08Pham Quang XSell5.89K$4.3825.81K
2026-06-05Pham Quang XSell2.06K$4.429.12K
2026-06-04Pham Quang XSell3.90K$4.4117.19K
2026-06-03Pham Quang XSell2.32K$4.269.90K
2026-06-02Pham Quang XSell349$4.461.56K
2026-05-29Pham Quang XSell303$5.011.52K
2026-05-28Pham Quang XSell2.99K$4.9314.74K
2026-05-22Pham Quang XSell1.17K$5.696.63K
2026-05-12Pham Quang XSell3.30K$5.2817.41K
2026-05-11Pham Quang XSell6.48K$5.7637.30K
2025-12-29Szot Matthew KSell9.93K$6.9769.23K
2025-12-02Golden Lee ScottBuy5.00K$8.2741.35K
2025-11-24Golden Lee ScottOther0——
2025-10-27Szot Matthew KSell1.80K$13.9925.18K
2025-10-27Pham Quang XSell1.31K$13.9918.40K
2025-10-24Szot Matthew KSell1.80K$13.9925.18K
2025-10-24Pham Quang XSell1.13K$14.0315.84K
2025-10-13Szot Matthew KSell1.80K$14.0725.33K
2025-10-13Pham Quang XSell1.80K$14.1525.47K
2025-10-09Szot Matthew KSell1.69K$13.9923.69K
2025-10-09Pham Quang XSell1.80K$14.0225.24K
2025-10-06Szot Matthew KSell107$13.991.50K
2025-10-02Pham Quang XSell500$14.137.07K
2025-10-01Szot Matthew KSell1.70K$13.9923.78K
2025-10-01Pham Quang XSell881$14.0112.34K
2025-09-29Szot Matthew KSell100$14.001.40K
2025-09-29Pham Quang XSell419$14.015.87K
2025-09-25Szot Matthew KSell10.90K$14.05153.18K
2025-09-25Pham Quang XSell6.79K$14.0995.67K
2025-09-24Szot Matthew KSell1.50K$14.0020.99K
2025-09-24Pham Quang XSell2.58K$13.9936.11K
2025-08-28Szot Matthew KSell400$14.005.60K
2025-08-28Pham Quang XSell1.19K$13.9916.69K
2025-08-27Szot Matthew KSell1.60K$13.9922.39K
2025-08-27Pham Quang XSell3.84K$13.9953.67K
2025-02-05Ferguson James J. IIIBuy60.00K$19.751.19M
2025-02-05Ferguson James J. IIIOther0——
2025-02-01Cole Jeffrey ScottSell150.00K$0.94141.00K
2025-01-23Pham Quang XBuy65.00K$19.791.29M
2025-01-23MURPHY JOHN RAYMONDBuy20.00K$19.79395.80K
2025-01-23WILSON GLYNNBuy20.00K$19.79395.80K
2025-01-23Zelenkofske StevenBuy20.00K$19.79395.80K
2025-01-23Cole Jeffrey ScottBuy25.00K$19.79494.75K
2025-01-23Szot Matthew KBuy50.00K$19.79989.50K
2025-01-23Pham Quang XBuy65.00K$21.771.41M
2025-01-23Lisicki RobertBuy20.00K$19.79395.80K
2024-04-10Pham Quang XSell50.00K——
2024-04-02Cole Jeffrey ScottBuy150.00K$0.6293.00K
2024-01-18Zelenkofske StevenBuy100.00K$0.9494.00K
2024-01-18MURPHY JOHN RAYMONDBuy100.00K$0.9494.00K
2024-01-18Lisicki RobertBuy50.00K$0.9447.00K
2024-01-18Pham Quang XBuy150.00K$0.94141.00K
2024-01-18Szot Matthew KBuy250.00K$0.94235.00K
2024-01-18WILSON GLYNNBuy70.00K$0.9465.80K
2024-01-18LOSORDO DOUGLAS WBuy150.00K$0.94141.00K
2023-10-23Pham Quang XSell85.00K——
2023-10-05MURPHY JOHN RAYMONDBuy2.67K$0.691.84K
2023-10-04MURPHY JOHN RAYMONDBuy17.33K$0.7012.13K
2023-09-05Pham Quang XBuy20.00K$0.9017.99K
2023-09-05Pham Quang XBuy20.00K$0.9118.20K
2023-09-01Pham Quang XBuy10.00K$0.848.43K
2023-09-01Pham Quang XBuy10.00K$0.929.17K
2023-09-01Pham Quang XBuy20.00K$0.9218.44K
2023-09-01Pham Quang XBuy20.00K$0.9318.58K
2023-09-01Pham Quang XBuy10.00K$0.939.32K
2023-08-18LOSORDO DOUGLAS WSell300.00K$0.64192.00K
2023-07-23Lisicki RobertBuy75.00K$1.2090.00K
2023-07-23Lisicki RobertOther0——
2023-07-11Zelenkofske StevenSell50.00K$0.6432.00K
2023-03-21MURPHY JOHN RAYMONDBuy10.00K$1.3913.90K
2023-03-16MURPHY JOHN RAYMONDBuy20.00K$1.6733.40K
2023-02-10Pham Quang XBuy25.00K$1.9448.50K
2023-01-24WILSON GLYNNBuy50.00K——
2023-01-24WILSON GLYNNSell50.00K——
2023-01-24Szot Matthew KBuy50.00K——
2023-01-24MURPHY JOHN RAYMONDBuy514.79K——
2023-01-24MURPHY JOHN RAYMONDSell514.79K——
2023-01-19Zelenkofske StevenSell0——
2023-01-19WILSON GLYNNSell50.00K$1.0050.00K
2023-01-19Szot Matthew KSell0——
2023-01-19Pham Quang XSell0——
2023-01-19Pham Quang XOther0——
2023-01-19MURPHY JOHN RAYMONDSell514.79K$1.00514.79K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 17, holders 0 vs prior quarter. Ownership 3.86%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC50.14K4.94K+10.92%167.46K
HRT FINANCIAL LP29.05K29.05KNew97.00K
GEODE CAPITAL MANAGEMENT, LLC19.02K-2.60K-12.03%63.54K
VANGUARD FIDUCIARY TRUST CO8.31K00.00%27.76K
TOWER RESEARCH CAPITAL LLC (TRC)1.28K889+226.21%4.28K
UBS GROUP AG1.11K1.11K+36966.67%3.71K
GROVE BANK & TRUST1.00K1.00KNew3.34K
MORGAN STANLEY706606+606.00%2.36K
CLEARSTEAD ADVISORS, LLC650650New2.17K
QUEST 10 WEALTH BUILDERS, INC.380380New1.27K
OSAIC HOLDINGS, INC.30000.00%1.00K
ROCKEFELLER CAPITAL MANAGEMENT L.P.15000.00%501
WELLS FARGO & COMPANY/MN9900.00%331
BARCLAYS PLC9393New311
INTEGRATED WEALTH CONCEPTS LLC8686New287
ARCHER INVESTMENT CORP3500.00%117
IFP ADVISORS, INC3000.00%100
CYGNUS CAPITAL ADVISORS, LLC0-1.49K-100.00%0
CITIGROUP INC0-1-100.00%0
DESTINY WEALTH PARTNERS, LLC0-200-100.00%0
BLACKROCK, INC.0-5.50K-100.00%0
CURIO WEALTH, LLC0-1-100.00%0
JPMORGAN CHASE & CO0-7.50K-100.00%0

Earnings and financials

Cadrenal Therapeutics, Inc. Common Stock (CVKD) trades at $0.92, with a market cap of $3.29M and a trailing P/E of -0.20. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2022202320242025
0000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cadrenal Therapeutics (CVKD) Financials: Revenue & Earnings

CVKD$0.92-0.02 -2.13%

$3.29M

Market Cap

-0.20

P/E

0.11

Forward P/E

—

Score

Price History